International prognostic index is the best prognostic factor for survival in patients with AIDS-related non-Hodgkin's lymphoma treated with CHOP. A multivariate study of 46 patients

Haematologica

Volumn 83, Issue 6, 1998, Pages 508-513

  Navarro, José Tomas ^a   Ribera, Josép Maria ^a   Oriol, Albert ^a   Vaquero, Manuel ^a   Romeu, Joan ^a   Batlle, Montserrat ^a   Gómez, Joaquin ^a   Millá, Fuensanta ^a   Feliu, Evarist ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

AIDS; CHOP; International Prognostic Index; Lymphoma; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIPROTOZOAL AGENT; ANTIRETROVIRUS AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROCORTISONE; METHOTREXATE; NUCLEOSIDE ANALOG; PENTAMIDINE; PREDNISONE; PROTEINASE INHIBITOR; VINCRISTINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS RELATED COMPLEX; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; LYMPHOMA; MALE; NEUROTOXICITY; NEUTROPENIA; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; PROGNOSIS; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; LYMPHOMA, AIDS-RELATED; MALE; MULTIVARIATE ANALYSIS; PREDNISONE; PROGNOSIS; REFERENCE STANDARDS; SURVIVAL ANALYSIS; VINCRISTINE;

EID: 0031820027     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Centers for Disease Control: revision of the case definition of acquired immunodeficiency syndrome for national reporting-United States. MMWR 1985; 34: 373-5.
2. Biggar RJ, Rabkin CS. The epidemilogy of acquired immunodeficiency syndrome-related lymphomas. Curr Opin Oncol 1992; 4:883-93.
3. Schultz TF, Boshoff CH, Weiss RA. HIV infection and neoplasia. Lancet 1996; 348:587-91.
4. Carbone A, Gaidano G. HHV-8-positive body-cavity-based lymphoma: a novel lymphoma entity. Br J Haematol 1997; 97:515-22.
5. Levine AM. Acquired immunodeficiency syndrome-related lymphoma. Blood 1992; 80:8-20.
6. Gisselbrecht C, Oksenhendler E, Tirelli U, et al. Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. Am J Med 1993; 95:188-96.
7. Tirelli U, Spina M, Vaccher E, et al. Clinical evaluation of 451 patients with HIV related non-Hodgkin's lymphoma: experience of the Italian Cooperative Group on AIDS and Tumors (GICAT). Leuk Lymphoma 1995; 20:91-6.
8. Kaplan LD, Straus DJ, Testa MA, et al. Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. N Engl J Med 1997; 336:1641-8.
9. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981; 47:207-14.
10. Harris NL, Jaffe ES, Stein H, et al. A Revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84:1361-92.
11. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971; 31:1860-1.
12. Musshoff K. Klinische stadieneinteinlung der nicht-Hodgkin lymphome. Strahlentherapie 1977; 153:218-21.
13. The International non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 987-94.
14. Centers for Disease Control: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS adolescents and adults. MMWR 1992; 41:1-18.
15. Kaplan EL, Meier P. Non parametric estimations from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
16. Peto R, Pike MC. Conservatism of the approximation S(0-E)2/E in the log-rank test for survival data or tumor incidence data. Biometrics 1973; 29:579-84.
17. Cox DR. Regression models and life tables. J R Stat Soc 1972; 3:187-220.
18. Beral V, Peterman T, Berkelman R, Jaffe H. AIDS-associated non-Hodgkin's lymphoma. Lancet 1991; 337: 805-9.
19. Stephen J, Dutoit H, Pallesen G, et al. AIDS-related lymphoma. Histopathology, immunophenotype, and association with Epstein-Barr virus is demonstrated by in situ nucleic acid hybridization. Am J Pathol 1991; 138: 149-63.
20. Ribera JM. Lymphomas in patients with human immunodeficiency virus infection. A bad present, a better future? Med Clin (Barc) 1995; 104:500-2.
21. Levine A. AIDS-related malignancies: the emerging epidemics. J Natl Cancer Inst 1993; 85:1382-97.
22. Sparano JA, Wiernik PH, Hu X, et al. Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma. J Clin Oncol 1996; 14:3026-35.
23. Tosi P, Gherlinzoni F, Mazza P, et al. 3′-azido 3′-deoxythymidine+methotrexate as a novel antineoplastic combination in the treatment of human immunodeficiency virus-related non-Hodgkin's lymphomas. Blood 1997; 89:419-25.
24. Tirelli U, Errante D, Carbone A, Gloghini A, Vaccher E. Malignant lymphomas in patients with HIV infection. Leuk Lymphoma 1996; 22:245-55.
25. Walsh C, Wernz JC, Levine A, et al. Phase-I trial of M-BACOD and granulocyte-macrophage colony stimulating factor in HIV-associated non-Hodgkin's lymphoma. J Acquir Immune Defic Syndr 1993; 6:265-71.
26. Tirelli, Vaccher E. Economic and clinical evaluation of therapy of HIV-related non-Hodgkin's lymphoma with chemotherapy and granulocyte colony-stimulating factor (G-CSF). Eur J Cancer 1994; 30A:1589-90.
27. Navarro JT, Ribera JM, Gómez-Espuch J, Feliu E. The effect of G-CSF after chemotherapy with CHOP in patients with non-Hodgkin's lymphoma and HIV infection. Med Clin (Barc) 1996; 107:118-9.
28. Sandler AS, Kaplan LD. Diagnosis and management of systemic non-Hodgkin's lymphoma in HIV disease. Hematol Oncol Clin North Am 1996; 10:1111-23.
29. Faulds D, Brogden RN. Didanosine. Drugs 1992; 44:94-116.
30. th Annual meeting of the American Society of Hematology. Blood 1997; 90 (Suppl 1).
31. Vaccher E, Tirelli U, Spina M, et al. Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: a single-institution study of 96 patients. J Clin Oncol 1996; 14: 2217-23.
32. Kaplan LD, Abrams DI, Feigal E, et al. AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA 1989; 261:719-24.
33. Levine AM, Gill PS, Meyer PR, et al. Retrovirus and malignant lymphoma in San Francisco. JAMA 1985; 254:1921-5.